Hongyan Sun
Papers
2
Total Citations
12
H-Index
2
About
Hongyan Sun is a pioneering researcher at the intersection of biomedical engineering, nanotechnology, and targeted drug delivery, with a focus on developing innovative solutions for cancer treatment and micromanipulation. Their work centers on harnessing magnetic actuation systems to engineer intelligent micro/nanorobots capable of precise, controllable interactions within complex biological environments. Sun's most notable contribution lies in the development of dual-responsive magnetic nanoparticles for hepatocellular carcinoma (HCC) — one of the world's deadliest cancers — demonstrating how magnetically guided drug delivery can significantly enhance tumor-targeting precision while minimizing systemic side effects compared to conventional molecularly targeted therapies. This 2024 study has already garnered 8 citations, signaling rapid uptake in the oncology and nanomedicine communities. Complementing this, Sun's collaborative work on magnetically actuated cell-robot systems established new benchmarks in micromanipulation accuracy, enabling controlled transport of microspheres and biological cells through externally applied magnetic fields, accumulating 4 citations since 2022. Together, these contributions reflect Sun's broader vision of bridging robotics, magnetic control, and biomedicine to create next-generation therapeutic platforms — work that holds transformative potential for precision oncology and minimally invasive biomedical interventions.
Research Focus
Key Achievements
Top Papers
- 1
- 2